CCORF analyst Kyle Mikson CFA maintains $Castle Biosciences (CSTL.US)$ with a buy rating, and maintains the target price at $42.
According to TipRanks data, the analyst has a success rate of 29.3% and a total average return of -15.7% over the past year.
Furthermore, according to the comprehensive report, the opinions of $Castle Biosciences (CSTL.US)$'s main analysts recently are as follows:
Castle Biosciences reported a solid third quarter, with revenues meeting expectations and encouraging operational expenditure leverage. While overall volumes increased, dermatology volumes were slightly below estimates, attributed to seasonal effects. Moreover, the TissueCypher product continued to show compelling momentum.
Attention towards coverage determination for the SCC test persists, yet it's observed that the company is advancing its volume for additional tests, including IDgenetix and TissueCypher. The robust performance of these tests played a significant role in the impressive quarterly results and the subsequent elevation in revenue guidance.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
